Literature DB >> 31986036

Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA.

Pan Xu1, Quentin Kaas2, Yong Wu1, Xiaopeng Zhu1, Xincan Li1, Peta J Harvey2, Dongting Zhangsun1, David J Craik2, Sulan Luo1.   

Abstract

αO-conotoxin GeXIVA from Conus generalis is a potent antagonist of the α9α10 nAChR and analgesic in animal models of pain. This peptide has two disulfide bond cross-links, and the bead and ribbon isomers have similar inhibitory activity against α9α10 nAChRs. We synthesized 12 disulfide-deficient analogues of bead GeXIVA, and all remained potent inhibitors of α9α10 nAChR. The most potent disulfide-deficient analogue displayed IC50 values of 6 and 33 nM at rat and human α9α10 nAChRs, respectively, representing less than a 2-fold increase compared with bead GeXIVA. The disulfide-deficient analogs and parent peptides also do not have a well-defined structure according to NMR spectroscopy. Molecular simulations suggest that the disulfide bonds and termini of GeXIVA do not establish stable interactions with the receptor. Overall, this study proposes that the structure of the analgesic peptide GeXIVA could be simplified through disulfide bond deletions and potentially termini truncations.

Entities:  

Year:  2020        PMID: 31986036     DOI: 10.1021/acs.jmedchem.9b01409

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

Review 1.  Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology.

Authors:  Andrea Becchetti; Laura Clara Grandi; Giulia Colombo; Simone Meneghini; Alida Amadeo
Journal:  Brain Sci       Date:  2020-11-25

2.  Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency.

Authors:  Lu Li; Zhiguo Li; Yongxin Guo; Kai Zhang; Weidong Mi; Jing Liu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.